ÌÇÐÄÆƽâ°æ

Market share of leading weight loss drugs worldwide from the second quarter of 2024 to the first quarter of 2025

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

August 2025

Region

Worldwide

Survey time period

Q2 2024 to Q1 2025

Citation formats

Market share of leading weight loss drugs worldwide Q2 2024-Q1 2025

Published by A. Minhas, Jan 19, 2026

As of the first quarter of 2025, Novo Nordisk’s ** held the largest market share in the global weight-loss drug market, followed by Eli Lilly’s *** with a ** percent share. The Danish company Novo Nordisk and the U.S.-based Eli Lilly remain the dominant players in the field of weight-loss drugs.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Novo Nordisk "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Novo Nordisk

Global positioning

6

Key metrics

4

Segments

4

Competitors

5

Diabetes & weight loss - a growing market

5

Further Content: You might find this interesting as well

Topics

Novo NordiskGlobal pharmaceutical industryPharmaceutical industry in the U.S.DiabetesDiabetes in China
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.